Raymond James Financial Inc Chroma Dex Corp. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Raymond James Financial Inc holds 154,229 shares of CDXC stock, worth $869,851. This represents 0.0% of its overall portfolio holdings.
Number of Shares
154,229Holding current value
$869,851% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CDXC
# of Institutions
105Shares Held
17.7MCall Options Held
66.7KPut Options Held
8.2K-
Vanguard Group Inc Valley Forge, PA3.43MShares$19.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$17.6 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.96MShares$16.7 Million5.59% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.31 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.48 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $385M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...